|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis显示文摘 | Lucio Amitrano Maria Anna Guardascione Vincenzo Brancaccio Maurizio Margaglione Francesco Manguso Luigi Iannaccone Elvira Grandone Antonio Balzano | 2004 | Journal of Hepatology2004，，5： | 2 |
| 2 | High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis显示文摘 | Lucio Amitrano Vincenzo Brancaccio Maria Anna Guardascione Maurizio Margaglione Luigi Iannaccone Giovanna D’Andrea Paul R.J Ames Riccardo Marmo Sandro Mosca Antonio Balzano | 2001 | The American Journal of Gastroenterology2001，，1： | 1 |
| 3 | Occurrence of the JAK2 V617F mutation in the Budd–Chiari syndrome显示文摘 | Donatella Colaizzo Lucio Amitrano Giovanni L Tiscia Luigi Iannaccone Anna Gallone Elvira Grandone Maria A Guardascione Maurizio Margaglione | 2008 | Blood Coagulation & Fibrinolysis2008，，5： | 1 |
| 4 | Coagulation Disorders in Liver Disease显示文摘 | Lucio Amitrano Maria Guardascione Vincenzo Brancaccio Antonio Balzano | 2002 | Semin Liver Dis2002，，01： | 1 |
| 5 | Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis显示文摘 | Lucio Amitrano Maria Anna Guardascione Vincenzo Brancaccio Maurizio Margaglione Francesco Manguso Luigi Iannaccone Elvira Grandone Antonio Balzano | 2004 | Journal of Hepatology2004，，5： | 1 |
| 6 | Risk factors and clinical presentation of portal vein thrombosis in pa- tlents with liver cirrhosis显示文摘 | Lucio Amitrano Maria Anna Guardascione Vinceuzo Brancaccio | 2004 | Joumaal of hepatology2004，40，： | 1 |
| 7 | Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis显示文摘 | Lucio Amitrano Maria Anna Guardascione Antonella Menchise Rossana Martino Mariano Scaglione Sabrina Giovine Luigia Romano Antonio Balzano | 2010 | Journal of Clinical Gastroenterology2010，，6： | 1 |
| 8 | Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis显示文摘 | Lucio Amitrano Maria Anna Guardascione Antonella Menchise Rossana Martino Mariano Scaglione Sabrina Giovine Luigia Romano Antonio Balzano | 2010 | Journal of Clinical Gastroenterology2010，，： | 1 |
| 9 | Role of multidetector computed tomography angiography in nonvariceal upper gastrointestinal bleeding:A comprehensive review显示文摘Non-variceal upper gastrointestinal bleeding(NVUGIB)is a common gastroenterological emergency associated with significant morbidity and mortality.Upper gastrointestinal endoscopy is currently recommended as the gold standard modality for both diagnosis and treatment,with computed tomography traditionally playing a limited role in the diagnosis of acute NVUGIB.Following the introduction of multidetector computed tomography(MDCT),this modality is emerging as a promising tool in the diagnosis of NVUGIB.However,to date,evidence concerning the role of MDCT in the NVUGIB diagnosis is still lacking.The aim of our study was to review the current evidence concerning the role of MDCT in the diagnosis of acute NVUGIB. | Alberto Martino Marco Di Serafino Lucio Amitrano Luigi Orsini Lorena Pietrini Rossana Martino AntonellaMenchise Luca Pignata Luigia Romano Giovanni Lombardi | 2022 | World Journal of Gastrointestinal Endoscopy2022，14，12： | 0 |
| 10 | The role of computed tomography for the prediction of esophageal variceal bleeding:Current status and future perspectives显示文摘Esophageal variceal bleeding(EVB)is one of the most common and severe complications related to portal hypertension(PH).Despite marked advances in its management during the last three decades,EVB is still associated with significant morbidity and mortality.The risk of first EVB is related to the severity of both PH and liver disease,and to the size and endoscopic appearance of esophageal varices.Indeed,hepatic venous pressure gradient(HVPG)and esophagogastroduodenoscopy(EGD)are currently recognized as the“gold standard”and the diagnostic reference standard for the prediction of EVB,respectively.However,HVPG is an invasive,expensive,and technically complex procedure,not widely available in clinical practice,whereas EGD is mainly limited by its invasive nature.In this scenario,computed tomography(CT)has been recently proposed as a promising modality for the non-invasive prediction of EVB.Although CT is only a diagnostic modality,thus being not capable of supplanting EGD or HVPG in providing therapeutic and physiological data,it could potentially assist liver disease scores,HVPG,and EGD in a more effective prediction of EVB.However,to date,evidence concerning the role of CT in this setting is still lacking.Our review aimed to summarize and discuss the current evidence concerning the role of CT in predicting the risk of EVB. | Alberto Martino Lucio Amitrano Marianna Guardascione Marco Di Serafino Raffaele Bennato Rossana Martino Annalisa de Leone Luigi Orsini Luigia Romano Giovanni Lombardi | 2023 | World Journal of Gastrointestinal Endoscopy2023，15，12： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员